Clinical Study of the Effect of Combined Treatment of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Zileuton (Primary) ; Aspirin
- Indications Lung cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 20 Jan 2016 Planned primary completion date changed from 1 Aug 2017 to 1 Feb 2018 as reported by ClinicalTrials.gov.
- 20 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.